Last reviewed · How we verify

pethidine and haloperidol injection

Hospital General Universitario Gregorio Marañon · FDA-approved active Small molecule

Pethidine acts as an opioid analgesic while haloperidol acts as a dopamine antagonist antipsychotic, together providing analgesia and sedation with antipsychotic effects.

Pethidine acts as an opioid analgesic while haloperidol acts as a dopamine antagonist antipsychotic, together providing analgesia and sedation with antipsychotic effects. Used for Acute pain management with sedation and anxiolysis in hospital settings, Pain management in patients requiring antipsychotic or antiemetic effects.

At a glance

Generic namepethidine and haloperidol injection
Also known asmeperidine and haloperidol injection
SponsorHospital General Universitario Gregorio Marañon
Drug classOpioid analgesic + typical antipsychotic combination
TargetMu opioid receptor (pethidine); dopamine D2 receptor (haloperidol)
ModalitySmall molecule
Therapeutic areaPain management / Psychiatry
PhaseFDA-approved

Mechanism of action

Pethidine is a synthetic opioid that binds to mu opioid receptors in the central nervous system to produce analgesia and sedation. Haloperidol is a typical antipsychotic that blocks dopamine D2 receptors, providing antipsychotic and antiemetic effects. This combination is used for acute pain management with sedation and to reduce agitation or psychotic symptoms.

Approved indications

Common side effects

Key clinical trials

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

SourceUsed for
ClinicalTrials.govTrial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: